235 related articles for article (PubMed ID: 23406679)
1. Epigenetic inactivation of the MIR129-2 in hematological malignancies.
Wong KY; Yim RL; Kwong YL; Leung CY; Hui PK; Cheung F; Liang R; Jin DY; Chim CS
J Hematol Oncol; 2013 Feb; 6():16. PubMed ID: 23406679
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the miR-124-1 in haematological malignancies.
Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS
PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of the miR-34a in hematological malignancies.
Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of MIR203 in multiple myeloma.
Wong KY; Liang R; So CC; Jin DY; Costello JF; Chim CS
Br J Haematol; 2011 Sep; 154(5):569-78. PubMed ID: 21707582
[TBL] [Abstract][Full Text] [Related]
7. miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.
Zhang MY; Wang LQ; Chim CS
Cell Commun Signal; 2021 May; 19(1):62. PubMed ID: 34044822
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Silencing of Tumor Suppressor lncRNA
Zhang MY; Calin G; Deng MD; Au-Yeung RKH; Wang LQ; Chim CS
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052468
[TBL] [Abstract][Full Text] [Related]
12. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
Wang LQ; Wong KY; Rosèn A; Chim CS
Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Wang LQ; Wong KY; Li ZH; Chim CS
Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
[TBL] [Abstract][Full Text] [Related]
15. Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.
Yim RL; Wong KY; Kwong YL; Loong F; Leung CY; Chu R; Lam WW; Hui PK; Lai R; Chim CS
Oncotarget; 2014 Oct; 5(20):9770-82. PubMed ID: 25211095
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.
Tao YF; Xu LX; Lu J; Cao L; Li ZH; Hu SY; Wang NN; Du XJ; Sun LC; Zhao WL; Xiao PF; Fang F; Li YH; Li G; Zhao H; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
J Transl Med; 2014 Jun; 12():182. PubMed ID: 24962166
[TBL] [Abstract][Full Text] [Related]
18. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.
Guillaumet-Adkins A; Richter J; Odero MD; Sandoval J; Agirre X; Catala A; Esteller M; Prósper F; Calasanz MJ; Buño I; Kwon M; Court F; Siebert R; Monk D
J Hematol Oncol; 2014 Jan; 7():4. PubMed ID: 24405639
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of EVL/miR-342 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chng WJ; Chim CS
Transl Res; 2018 Feb; 192():46-53. PubMed ID: 29242101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]